Jeff Nielson | TalkMarkets | Page 4
Independent Information Services Professional
Contributor's Links: Psychedelic Stock Watch
Jeff Nielson is a business writer from Vancouver, Canada who covers markets and the economy. With an academic background in economics and law, he provides a unique perspective in economic trends and market opportunities. In covering markets, Jeff has worked with over 100 public companies spanning ...more

Articles

Latest Posts
49 to 64 of 89 Posts
How Psychedelic Drug Stocks Took Off In 2020
One of the most explosive stock market rallies in all of 2020 almost didn't happen.
Rotation Opportunity As Three Top Psychedelic Stocks Explode
With its first psychedelic-assisted treatment clinic preparing to open, Mind Cure Health is an undervalued rotation target.
Big Financings Powering Future Profits In Psychedelic Stocks
$400 million in investment capital has flooded into psychedelic drug companies in just the last 10 weeks. Investors take note.
The Psychedelics Revolution: It’s No Longer Bad To Feel Good
Today, the world is gripped by a horrific Mental Health Crisis, a mental health epidemic of stress-related conditions (like depression, anxiety, addiction, and PTSD) that afflicts over 1 billion people around the world.
Why An ATAI IPO Is Driving MindMed Stock
ATAI Life Sciences has announced its going public in Spring 2021. MindMed Inc has exploded on this news. Find out why the two events are connected.
Major Buying Opportunity For SKRR As Winter Drilling Program Announced
Gold mining stock share prices are currently depressed. SKRR Exploration has two sets of drill results on the way -- sitting with a market cap of only CAD$9 million. Major buying opportunity.
Psychedelic Drug Therapy: Cure Your Mind, Save Your Heart?
A growing body of clinical research indicates that psychedelic drugs can be very effective in treating depression and anxiety (among other conditions). New research indicates that such therapies may also reduce the risk of heart disease.
More U.S. Military Funding For Psychedelic Drug R&D As PTSD Crisis Worsens
From crisis comes opportunity. The worsening PTSD crisis among military personnel (and first responders) may be the quickest path to legalization for a new psychedelic medicine.
A Market Reality Check For Psychedelic Stocks
The Psychedelics Revolution is here to stay. The solutions of tomorrow are the investments of today.
New Psychedelic Stocks: The Menu Is Getting Longer For Investors
Three new psychedelic stocks are trading publicly. One commenced trading last week, two more are coming this week.
Gold And Silver Explode Higher, Mining Stocks Cheap
In a sea of over-priced equities, gold and silver mining stocks stand out as outstanding value propositions.
What Oregon Psilocybin Legalization Means For The Psychedelic Drug Industry
We explain why psychedelic drug stocks are surging on news that Oregon has legalized psilocybin for medicinal use.
Psychedelics Revolution Front-And-Center As Americans Prepare To Vote
Backed by strong corporate and media support, the psychedelic drug industry is set to move forward regardless of the outcome of today’s election.
Huge Cost-Savings From Psychedelic Drug Therapy
A new MAPS study citing major cost savings for a psychedelics-based therapy is the final necessary ingredient for psychedelic drug industry success.
The 4 Best-Performing Psychedelic Stocks
As the new rally in psychedelic stocks progresses, these four companies are currently setting the pace.
How And Why Psychedelic Drugs Can Conquer The Mental Health Crisis
The emerging psychedelic drug industry is thriving. It has attracted a multitude of high-profile investors.
49 to 64 of 89 Posts